Michelle Bradbury
MI3 Director · New York Presbyterian Hospital
Credentials: · · ·
History
- 2002–2003
- 1998–2002
Radiology-Diagnostic
- 1997–1998
Preliminary or Transitional Year
- 1989–1993
Research
Nature Nanotechnology · 2016 · 487 citations
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Science Translational Medicine · 2014 · Last of 14 authors · Corresponding · 483 citations
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
Journal of Clinical Investigation · 2011 · Last of 14 authors · 425 citations
- SL
6 papers
- CB
5 papers
4 papers
- SP
4 papers
3 papers
3 papers
- HS
3 papers
3 papers
Grants
- 2020–2027
National Cancer Institute · R01
Contact PI · $3M · Weill Medical Coll of Cornell Univ
- 2020–2026
National Cancer Institute · R01
Contact PI · $2.1M · Weill Medical Coll of Cornell Univ
- 2015–2021
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
National Cancer Institute · U54
Contact PI · $8.3M · Sloan-Kettering Inst Can Research
- 2012–2018
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra
National Cancer Institute · R01
Contact PI · $2.7M · Sloan-Kettering Inst Can Research
Clinical trials
- 2019–2024
A Study of a Device Used to Take Pictures of Skin Blood Flow
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2009–2020
Image-Guided Stereotactic Biopsy of High Grade Gliomas
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center